Basics |
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs.
|
IPO Date: |
April 12, 2006 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$314.95M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.24 | 2.38%
|
Avg Daily Range (30 D): |
$0.10 | 2.08%
|
Avg Daily Range (90 D): |
$0.09 | 1.84%
|
Institutional Daily Volume |
Avg Daily Volume: |
.57M |
Avg Daily Volume (30 D): |
.43M |
Avg Daily Volume (90 D): |
.4M |
Trade Size |
Avg Trade Size (Sh.): |
141 |
Avg Trade Size (Sh.) (30 D): |
96 |
Avg Trade Size (Sh.) (90 D): |
105 |
Institutional Trades |
Total Inst.Trades: |
3,108 |
Avg Inst. Trade: |
$1.5M |
Avg Inst. Trade (30 D): |
$.97M |
Avg Inst. Trade (90 D): |
$1.24M |
Avg Inst. Trade Volume: |
.12M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.56M |
Avg Closing Trade (30 D): |
$.97M |
Avg Closing Trade (90 D): |
$1.06M |
Avg Closing Volume: |
121.04K |
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
|
$-.46
|
$-.5
|
Diluted EPS
|
|
$-.46
|
$-.5
|
Revenue
|
$
|
$ 52.59M
|
$ 50.04M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$
|
$ -27.21M
|
$ -29.49M
|
Operating Income / Loss
|
$
|
$ -38.5M
|
$ -41.03M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$
|
$ -30.81M
|
$ 9.48M
|
PE Ratio
|
|
|
|
|
|
|